New research at Washington University School of Medicine in St. Louis indicates that three new, fast-spreading variants of the virus that cause COVID-19 can evade antibodies that work against the original form of the virus that sparked the pandemic. With few exceptions, whether such antibodies were produced in response to...
Full ArticleNew Evidence COVID-19 Antibodies, Vaccines Less Effective Against Variants
Eurasia Review
0 shares
2 views
You might like
Related news coverage
Nvidia & darpa biohybrid
Rumble
https://www.youtube.com/watch?v=0Hg7XhbXuac . No One is Talking About What Just Happened..
Advertisement
More coverage
Areopagitica: Freedom Of Debate And Global Covid Challenge – Analysis
Eurasia Review
Seventeenth century British writer John Milton famously argued for freedom not just of speech but also of ideas and argument, as..
-
Tiziana Life Sciences plans phase II trials of nasal antibody treatment in COVID-19 patients
Proactive Investors
-
Tiziana Life Sciences planning phase II clinical trial of monoclonal antibody treatment in patients with moderate to severe COVID-19
Proactive Investors
-
COVID vaccine found highly effective in real-world US study
SeattlePI.com
-
COVID-19: Analysis of the sensitivity of the UK (B.1.1.7) and South African (B.1.351) variants to SARS-CoV-2 neutralizing antibodies
Science Daily